1-(2, 4-Dichlorophenyl)-1-(4-hydroxy-3-methoxybenzyl)-3-phenylurea (11a) | 1401205-06-8

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 1-(2, 4-Dichlorophenyl)-1-(4-hydroxy-3-methoxybenzyl)-3-phenylurea (11a)
• 英文别名: 1-(2,4-dichlorophenyl)-1-[(4-hydroxy-3-methoxyphenyl)methyl]-3-phenylurea
• CAS: 1401205-06-8
• 化学式: C₂₁H₁₈Cl₂N₂O₃
• 分子量: 417.292
• InChiKey: OSRVBRJJHLSZCE-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5
• 重原子数：
  28
• 可旋转键数：
  5
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.1
• 拓扑面积：
  61.8
• 氢给体数：
  2
• 氢受体数：
  3

反应信息

• 作为产物：
  描述：

  4-((2,4-Dichlorophenylimino)methyl)-2-methoxyphenol 在 sodium tetrahydroborate 作用下， 以 乙醇 、 氯仿 为溶剂， 反应 2.0h， 生成 1-(2, 4-Dichlorophenyl)-1-(4-hydroxy-3-methoxybenzyl)-3-phenylurea (11a)
  参考文献：
  名称：

  Synthesis and biological evaluation of novel N, N′-disubstituted urea and thiourea derivatives as potential anti-melanoma agents

  摘要：

  Two series of urea and thiourea derivatives (1a-11a, 1b-11b) have been synthesized; all the 22 compounds were reported for the first time. Their anti-proliferative activities against the melanoma cell line B16-F10 were evaluated. Among the compounds tested, compound 6b exhibited the most potent activity in melanoma cells growth inhibition (IC50 = 0.33 mu M). The bioassay tests showed that anti-proliferative activities of these novel compounds were possibly caused by inhibition of ERK1/2 phosphorylation level. Therefore, compound 6b can be a potential anti-melanoma agent and an inhibitor of ERK1/2 phosphorylation deserving further research.

  DOI：

  10.3109/14756366.2011.608665

文献信息

• Synthesis and biological evaluation of novel N, N′-disubstituted urea and thiourea derivatives as potential anti-melanoma agents
  作者：Qing-Shan Li、Peng-Cheng Lv、Huan-Qiu Li、Xiang Lu、Zi-Lin Li、Ban-Feng Ruan、Hai-Liang Zhu

  DOI：10.3109/14756366.2011.608665

  日期：2012.10.1

  Two series of urea and thiourea derivatives (1a-11a, 1b-11b) have been synthesized; all the 22 compounds were reported for the first time. Their anti-proliferative activities against the melanoma cell line B16-F10 were evaluated. Among the compounds tested, compound 6b exhibited the most potent activity in melanoma cells growth inhibition (IC50 = 0.33 mu M). The bioassay tests showed that anti-proliferative activities of these novel compounds were possibly caused by inhibition of ERK1/2 phosphorylation level. Therefore, compound 6b can be a potential anti-melanoma agent and an inhibitor of ERK1/2 phosphorylation deserving further research.